Home/Filings/4/0001209191-22-010239
4//SEC Filing

Richardson Charles E 4

Accession 0001209191-22-010239

CIK 0001786255other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:22 PM ET

Size

10.8 KB

Accession

0001209191-22-010239

Insider Transaction Report

Form 4
Period: 2022-02-14
Richardson Charles E
SVP, Technical Operations
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-02-1466,37543,489 total
    Exercise: $0.84Exp: 2029-09-12Common Stock (66,375 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-14$1.04/sh+6,186$6,433167,386 total
  • Exercise/Conversion

    Common Stock

    2022-02-14$0.84/sh+66,375$55,755161,200 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-02-146,18616,657 total
    Exercise: $1.04Exp: 2031-01-28Common Stock (6,186 underlying)
Footnotes (2)
  • [F1]25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter.
  • [F2]25% of the shares subject to the option vested on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter.

Issuer

Icosavax, Inc.

CIK 0001786255

Entity typeother

Related Parties

1
  • filerCIK 0001875096

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:22 PM ET
Size
10.8 KB